The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director role change

3 Jun 2019 07:01

RNS Number : 8893A
KRM22 PLC
03 June 2019
 

KRM22 plc

 

("KRM22" or the "Company")

 

 Director role change

 

KRM22 plc (AIM: KRM), the technology and software company focused on risk management in capital markets, announces that from 1st July 2019, Karen Bach, COO and one of the three founder directors, will become non-executive director. Karen will also be available to support the executive directors on strategic matters and investments.

 

Karen commented"KRM22 has exciting opportunities for growth and I am proud of how much the team has achieved in the year since IPO. We have built an excellent team culture and smooth-running environment with the right combination of skills, systems and sales focus. My executive role was focused on building the foundations to allow us to scale-up quickly and these are now in place."

 

Keith Todd, Chairman and CEO at KRM22, said: "On behalf of the Board and everyone at KRM22 I would like to thank Karen for the invaluable role she has played in taking KRM22 from concept to a successful AIM-listed business in such a short space of time. We are delighted that she will remain with the Company in a non-executive director role and support us strategically as we expand the depth and breadth of the Global Risk Platform."

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter Head of Finance

 

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets. 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEALKDELPNEEF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.